Skip to content

Inhalant allergen immunotherapy Survey

1.What country are you from?
2.Is allergen immunotherapy available in your country?
3.Is allergen immunotherapy funded by your national health system?
4.Where is your practice located?
5.What is your primary specialty?
6.Inhalant IT is used to treat:
7.Which is the indication you follow for this prescription?
8.Which of the following describes your practice type the best? Please select all that apply
9.In which location is the AIT administered?
10.In case it is administered in a medical facility, where is AIT administered?
11.What kind of administration route do you prescribe (Please select a percentage in all that apply)
12.Is your patient population mainly:
13.How many allergen extracts do you mix in the same immunotherapy vaccine in a polysensitized patient?
14.Which parameters do you use to guide AIT?
15.In case you use more than one extract in the same vaccine which type do you use?
16.In case you use more than one extract in the same vaccine which type of mixtures do you use?
17.What kind of extract do you use?
18.Do you use standardized extracts?
19.After how many years do you discontinue immunotherapy?
20.In case the decision to discontinue AIT is not made only the basis of time which criteria do you use: (more than 1 can be selected)
21.How long do you administer IT throughout the year?
22.What kind of immunotherapy build-up schedule do you use?
23.How many patients in your practice are currently undergoing an inhalant allergen immunotherapy?
24.Do you use any follow-up tool to promote adherence?
Privacy & Cookie Notice